Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bright Minds Biosciences Inc. - common stock
(NQ:
DRUG
)
91.20
-2.01 (-2.16%)
Streaming Delayed Price
Updated: 1:44 PM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bright Minds Biosciences Inc. - common stock
< Previous
1
2
3
4
5
Next >
The market is filled with gapping stocks in Wednesday's session.
↗
Today 10:30 EST
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
January 06, 2026
Via
Chartmill
Why Did DRUG Stock Rocket 51% Today?
↗
January 06, 2026
The Phase 2 BREAKTHROUGH trial met its primary goals, showing strong reductions in seizure frequency while maintaining a favorable safety profile.
Via
Stocktwits
Stay updated with the stocks that are on the move in today's pre-market session.
↗
January 06, 2026
Via
Chartmill
Why Bright Minds Biosciences Stock Topped the Market on Monday
↗
November 17, 2025
The company isn't wasting any time drafting seasoned professionals to help it develop medication for a rare genetic disorder.
Via
The Motley Fool
Large Patient Population Is Key Driver For Bright Minds' Growth
↗
September 08, 2025
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
Via
Benzinga
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside
↗
May 07, 2025
Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite limited clinical data.
Via
Benzinga
Biotechs on the Brink: 2 Stocks With Huge Potential
February 14, 2025
BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.
Via
MarketBeat
This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
January 23, 2025
Via
Benzinga
Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month
↗
November 13, 2024
The reason for the stock's rapid ascent is a mystery.
Via
The Motley Fool
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
↗
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
What's Going On With Bright Minds Biosciences Stock?
↗
October 21, 2024
Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday announced a new collaboration with brain health-focused AI company Firefly...
Via
Benzinga
Topics
Artificial Intelligence
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results
↗
October 18, 2024
Via
Benzinga
What's Going On With Bright Minds Biosciences Stock Friday?
↗
October 18, 2024
Bright Minds Biosciences shares are moving higher on Friday. The company announced a $35 million non-brokered private placement.
Via
Benzinga
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
↗
October 18, 2024
Via
Benzinga
Topics
Stocks
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
↗
October 17, 2024
Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI technology, setting the stage for Phase 2 trials.
Via
Benzinga
Topics
Artificial Intelligence
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
↗
October 16, 2024
Via
Benzinga
Topics
Stocks
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
↗
October 16, 2024
Via
Benzinga
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
↗
October 15, 2024
Via
Benzinga
Bright Minds Biosciences Reports Improved Financial Position For Q3 Amid Ongoing R&D Efforts
↗
August 16, 2024
Bright Minds Biosciences reports a significant reduction in net losses for Q3 2024 while advancing its R&D programs focused on serotonergic therapies for CNS disorders.
Via
Benzinga
DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q3 2024
↗
August 15, 2024
Bright Minds Biosciences just reported results for the third quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
August 12, 2024
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Via
InvestorPlace
DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q2 2024
↗
May 20, 2024
Bright Minds Biosciences just reported results for the second quarter of 2024.
Via
InvestorPlace
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
↗
April 17, 2024
Via
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
↗
March 29, 2024
Via
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
↗
March 20, 2024
Via
Benzinga
Topics
Economy
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
↗
March 04, 2024
Via
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
↗
February 15, 2024
Via
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
↗
February 15, 2024
Via
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
↗
January 27, 2024
New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
